Status:
COMPLETED
Methadone and Ketamine for Neuropathic Pain Treatment
Lead Sponsor:
Universidade Federal de Santa Maria
Collaborating Sponsors:
Santa Casa de Misericórdia de Belo Horizonte
Hospital de Clinicas de Porto Alegre
Conditions:
Neuropathic Pain
Eligibility:
All Genders
22-77 years
Phase:
PHASE4
Brief Summary
Methadone and ketamine are effective for neuropathic pain management. However, the benefits of the association of both drugs are uncertain. Here, the investigators conducted a randomized, double-blind...
Detailed Description
Either oral methadone or ketamine have been used in neuropathic pain management, however, the benefits of the association of both drugs are uncertain. Here, we conducted a randomized, double-blind, in...
Eligibility Criteria
Inclusion
- patients complaining of pain for more than 6 months with neuropathic pain poorly responsive to drugs used to treat neuropathic pain (i.e. opioid, non-opioid, anticonvulsants, antidepressants), who were 22 to 77 years old
Exclusion
- patients with a history of severe psychiatric disorder,
- misuse of illegal drugs or
- hepatic disease
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT02233452
Start Date
January 1 2012
End Date
August 1 2012
Last Update
September 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital in Santa Maria
Santa Maria, Rio Grande do Sul, Brazil, 97105-900